Intelligent Bio Solutions Inc.

NasdaqCM:INBS Stock Report

Market Cap: US$8.7m

Intelligent Bio Solutions Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of INBS?
Owner TypeNumber of SharesOwnership Percentage
Private Companies9,4000.139%
Individual Insiders94,7141.4%
Institutions378,4555.58%
Hedge Funds613,8929.06%
General Public5,682,26083.8%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 138.3%.

Top Shareholders

Top 16 shareholders own 16.2% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.06%
Alyeska Investment Group, L.P.
613,892US$785.8k198%no data
3.35%
Bigger Capital, LLC
227,274US$290.9k0%0.99%
1.12%
District 2 Capital LP
75,758US$97.0k1,100%1.16%
0.8%
Spiro Sakiris
53,930US$69.0k0%no data
0.6%
Harry Simeonidis
40,408US$51.7k0%no data
0.39%
Geode Capital Management, LLC
26,601US$34.0k17.1%no data
0.23%
The Vanguard Group, Inc.
15,485US$19.8k0%no data
0.23%
Two Sigma Securities, LLC, Asset Management Arm
15,397US$19.7k0%no data
0.15%
Ground Swell Capital, LLC
10,402US$13.3k0%0.03%
0.14%
Ionic Ventures, LLC
9,400US$12.0k0%no data
0.086%
Tower Research Capital Europe Limited
5,798US$7.4k445%no data
0.043%
UBS Asset Management AG
2,903US$3.7k87.2%no data
0.0046%
Stephen Boyages
313US$400.90%no data
0.003%
SBI Holdings Inc., Asset Management Arm
201US$257.70%no data
0.00093%
Jonathan Hurd
63US$80.70%no data
0.00053%
Bank of America Corporation, Asset Management Arm
36US$46.044%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/01 01:31
End of Day Share Price 2025/05/01 00:00
Earnings2024/12/31
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Intelligent Bio Solutions Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jeffrey CohenLadenburg Thalmann & Company
John VandermostenZacks Small-Cap Research